Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis

被引:41
作者
Kasapçopur, Ö [1 ]
Altun, S [1 ]
Aslan, M [1 ]
Karaarslan, S [1 ]
Kamburoglu-Göksel, A [1 ]
Saribas, S [1 ]
Arisoy, N [1 ]
Kocazeybek, B [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Med Sch, Dept Paediat Immunol & Microbiol, Istanbul, Turkey
关键词
D O I
10.1136/ard.2003.019331
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To correlate serum anti-cyclic citrullinated peptide antibodies (anti-CCP) levels with juvenile idiopathic arthritis (JIA) subtypes and with an erosive disease course. Methods: The study group comprised 122 children with JIA; 16 were evaluated during both active disease and remission. Nineteen children with systemic lupus erythematosus (SLE), 27 with rheumatoid arthritis ( RA), and 15 healthy children were also included in the study. Twelve children with JIA were rheumatoid factor (RF) positive, and 34 patients had persistent erosive joint disease. Anti-CCP antibody levels were determined by ELISA; values above 5 relative units were regarded as positive. Results: Three girls with seropositive polyarticular JIA and erosive joint disease had positive anti-CCP values. Children evaluated during active disease and remission, patients with SLE, and healthy children all had negative anti-CCP antibody levels. However, 19/27 (70%) adult patients with RA had positive anti-CCP antibody values. Conclusions: In contrast with RA, anti-CCP positivity is only rarely found in patients with JIA. In patients with RF positivity and/or in patients with erosive joint disease, anti-CCP can be detected.
引用
收藏
页码:1687 / 1689
页数:3
相关论文
共 17 条
[1]   Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis [J].
Avcin, T ;
Cimaz, R ;
Falcini, F ;
Zulian, F ;
Martini, G ;
Simonini, G ;
Porenta-Besic, V ;
Cecchini, G ;
Borghi, MO ;
Meroni, PL .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (07) :608-611
[2]  
Bizzaro N, 2001, CLIN CHEM, V47, P1089
[3]   Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis [J].
Cambridge, G ;
Leandro, MJ ;
Edwards, JCW ;
Ehrenstein, MR ;
Salden, M ;
Bodman-Smith, M ;
Webster, ADB .
ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2146-2154
[4]  
Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202
[5]   Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis [J].
Hromadnikova, I ;
Stechova, K ;
Vavrincova, P ;
Hridelova, D ;
Houbova, B ;
Voslarova, S ;
Nekvasilova, H ;
Vavrinec, J .
AUTOIMMUNITY, 2002, 35 (06) :397-401
[6]  
Jansen ALMA, 2002, J RHEUMATOL, V29, P2074
[7]   Clinical utility of the anti-CCP assay in patients with rheumatic diseases [J].
Lee, DM ;
Schur, PH .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (09) :870-874
[8]   The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α- and β-chains of fibrin [J].
Masson-Bessière, C ;
Sebbag, M ;
Girbal-Neuhauser, E ;
Nogueira, L ;
Vincent, C ;
Senshu, T ;
Serre, G .
JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :4177-4184
[9]   Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis [J].
Mediwake, R ;
Isenberg, DA ;
Schellekens, GA ;
van Venrooij, WJ .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (01) :67-68
[10]  
Petty Ross E., 1998, Journal of Rheumatology, V25, P1991